Arena Pharmaceuticals, Inc. (ARNA), VIVUS, Inc. (VVUS): Can the Newly Discovered Obesity Genes Help You Lose Weight?

Page 1 of 2

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)Overweight? You can now officially blame it on your parents. Or at least the genes they passed along to you.

Quite a few research papers published recently have shown that mutations in genes can control your appetite and your ability to burn calories. Genetic makeup affecting a person’s weight isn’t all that surprising, considering that people tend to have weight similar to their parents, but it’s nice to have an increasing body of scientific data to support the observation.

In one study, researchers showed deletions in the Mrap2 gene caused mice to weigh twice as much as their siblings even though they ate the same amount, implying the gene is involved in burning the calories.

Another gene, FTO, has long been linked to obesity, but a recent study showed how mutations in the gene leads to higher weight by increasing the level of ghrelin, a hormone that signals to the brain that you’re hungry.

In a third study, researchers sequenced the SIM1 gene, another gene associated with obesity, in 2,100 patients with severe, early-onset obesity and in 1,680 controls. They discovered 13 different variants in SIM1 in 28 unrelated obese patients, including several that weren’t found in the control patients that reduce the protein’s activity significantly.

A weighty issue
How’s this going to help you lose weight? It can’t. At least not yet.

Figuring out that you have one of these mutations is fairly easy. DNA sequencing is getting cheaper by the day. But it’s not as if you can change your genes. Maybe someday, but I’d guess not in your lifetime.

More likely, though, understanding the biology of obesity can help researchers develop drugs to control appetite and burn calories by interacting with the proteins involved in the metabolism process, especially if doctors know which proteins in the patient are functional.

For instance, a drug that increases FTO activity should lead to decreased appetite. Similarly, increasing Mrap2 activity may increase calories burned.

Like we’ve done already
With our limited knowledge of appetite and metabolism, drugmakers have already developed some drugs to treat obesity.

Eisai and Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)‘ Belviq activates the 5-HT2C receptor, which activates a polypeptide that makes you feel full. It’s easier to lose weight if you don’t feel like eating.

VIVUS, Inc. (NASDAQ:VVUS)‘ Qsymia is a combination of two drugs. Phentermine promotes reduced appetite through the release of catecholamines. The other component, topiramate that’s released over time, was originally developed by Johnson & Johnson to treat epilepsy. It isn’t clear exactly how the drug promotes weight loss, but there’s probably something going on in the brain, as the drug is also used to prevent migraines.

Contrave, being developed by Orexigen Therapeutics, Inc. (NASDAQ:OREX), is also a combination drug containing naltrexone and bupropion, the latter of which was developed by GlaxoSmithKline plc (ADR) (NYSE:GSK) as an antidepressant that is also used to help people stop smoking. Combined, the drugs stimulate pathways that increase energy expenditure and reduce appetite.

Orlistat, which is sold by Roche as Xenical and by GlaxoSmithKline plc (ADR) (NYSE:GSK) as a lower-dose over-the-counter formulation called Alli, reduces caloric intake by blocking the absorption of fats so they pass though the body.

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!